TT
TTK Healthcare Ltd (TTKHLTCARE)
₹1,110.15
Mkt cap
₹1,569 Cr
P/E ratio
21.60
P/B
1.16
Div yield
0.90%
ROE
6.30%
ROCE
8.04%
EPS (TTM)
₹51.40
Book value
₹953
52W range
735–1,247
Sector
Diversified
Price history
Previous close
TTK Healthcare Ltd is a standalone TTK Group company in consumer /OTC brands, animal health, medical devices, condoms/sexual-wellness and ready-to-fry foods. Human Pharma was divested in May 2022; agreements to sell EVA and Good Home were signed in July 2026. [1] [2]
NSE TTKHLTCAREBSE 507747
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthModerate
TechnicalsBullish
52-week range
−10.97% from high₹1,110
₹735+51.04% from low₹1,247
Current
₹1,110.15
Prev close
₹1,052.50
Day
+5.48%
Price performance
1D
+5.46%
1W
+18.28%
1M
+13.28%
3M
+2.58%
6M
+24.92%
1Y
−2.32%
YTD
+7.94%
Financials
Revenue, profit & margin
P/E ratio
21.6×
TTKHLTCARE is 58% above the sector median of 13.7×
TTKHLTCARE21.6×
Sector median13.7×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 186 | 184 | 181 | 208 | 198 | 205 | 190 | 226 | 204 | 209 | 218 | 258 | 233 | |
| YoY Sales growth | +9% | +1% | +1% | +3% | +7% | +11% | +5% | +9% | +3% | +2% | +15% | +14% | +15% | |
| Expenses | 176 | 179 | 169 | 201 | 190 | 197 | 178 | 224 | 198 | 202 | 207 | 243 | 230 | |
| Operating Profit | 10 | 5 | 12 | 7 | 8 | 8 | 12 | 3 | 5 | 7 | 11 | 15 | 4 | |
| OPM % | 5% | 2.9% | 7% | 3.3% | 4.2% | 3.8% | 6% | 1.2% | 2.6% | 3.4% | 5% | 6% | 1.6% | |
| Other Income | 16 | 16 | 16 | 37 | 18 | 18 | 13 | 18 | 19 | 10 | 21 | 17 | 267 | |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Depreciation | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
| Profit before tax | 22 | 18 | 24 | 41 | 23 | 23 | 22 | 18 | 21 | 14 | 30 | 29 | 268 | |
| Tax % | 26% | 27% | 25% | 23% | 26% | 26% | 26% | 26% | 4% | 25% | 26% | 26% | 17% | |
| Net Profit | 16 | 13 | 18 | 32 | 17 | 17 | 16 | 13 | 20 | 11 | 22 | 21 | 223 | |
| EPS in Rs | 11.33 | 9.12 | 12.93 | 22.35 | 12.17 | 11.84 | 11.43 | 9.20 | 14.43 | 7.45 | 15.40 | 15.06 | 157.80 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202674.57%Promoter
Promoters74.57%
FIIs1.95%0.09
DIIs0.11%2.08
Public23.37%1.98
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Godrej Industrie | ₹1,090.35 | 24.16 | 36,729 | 0.00% | 671 | +130.78% | 7,303 | +45.13% | 8.17% |
| 3M India | ₹28,255.00 | 78.04 | 31,843 | 0.57% | 158 | −17.17% | 1,452 | +14.69% | 50.01% |
| DCM Shriram | ₹882.00 | 10.45 | 13,754 | 1.27% | 106 | −33.66% | 3,977 | +21.55% | 11.51% |
| Balmer Lawrie | ₹166.44 | 9.42 | 2,846 | 5.11% | 79 | +40.54% | 801 | +26.01% | 14.60% |
| TTK Healthcare | ₹1,110.15 | 21.60 | 1,569 | 0.90% | 223 | −19.47% | 233 | +14.64% | 8.04% |
| Empire Inds. | ₹1,008.45 | 9.82 | 605 | 2.48% | 18 | +42.78% | 194 | +7.40% | 17.95% |
| Maheshwari Logi. | ₹70.96 | 13.66 | 210 | 0.00% | 4 | +3.84% | 266 | +0.23% | 12.04% |
| Median: 7 Co. | ₹1,008.45 | 13.66 | 2,846 | 0.90% | 106 | +3.84% | 801 | +14.69% | 12.04% |
Filings
Annual reports15
Concall transcripts1
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Scheme of Arrangement 20 Nov - Board approves bonus NCRPS: 5 for 1 equity at ₹100, ₹706.52 Cr, 9.5%, 15-month tenure.Board Meeting Outcome for Outcome Of Board Meeting 20 Nov - Board approves bonus issue of 5 NCRPS of ₹100 each per equity share, ₹706.52 cr, 9.5%, 15-month tenure.Closure of Trading Window 16 Nov - Board meets November 20, 2026 to consider bonus non-convertible redeemable preference shares; trading window closed Nov 16-22.Board Meeting Intimation for Board Meeting Intimation 16 Nov - Board meets November 20, 2026 to consider scheme of arrangement and bonus preference shares; trading window closes November 16-22.Announcement under Regulation 30 (LODR)-Newspaper Publication 3 Nov


